Mirati Therapeutics, Inc. (MRTX)
Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.
Address
3545 CRAY COURT
SAN DIEGO, CA 92121
Founded
1995
Number of Employees
593
Website
http://www.mirati.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)